Guidelines for measurement validation in clinical trial design.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Measurement Science

Background:

• Endpoint accuracy and precision are critical for valid clinical trial results.
• Endpoint reliability is assessed through reproducibility and consistency on repeated measurements.
• Agreement measures evaluate the consistency of measurements for endpoint validation.

Purpose of the Study:

• To examine the sensitivity of different agreement assessment methods to location and scale shifts.
• To provide guidelines for interpreting numerical results from agreement measures in clinical trials.
• To establish criteria for assessing endpoint agreement and validation.

Main Methods:

• Evaluated agreement assessment tools: Pearson's correlation coefficient, intraclass correlation coefficient, concordance correlation coefficient, Bradley-Blackwood procedure, and within-patient coefficient of variation.
• Conducted simulation studies to assess the sensitivity of these methods to location and scale shifts.
• Analyzed three key components for agreement: linear relationship, bias (mean difference), and variance difference.

Main Results:

• Simulation studies revealed situations where different agreement measures yield conflicting results.
• Agreement depends on the degree of linear relationship, bias, and variance differences between measurements.
• Established criteria for interpreting agreement measure values in the context of scale and location shifts.

Conclusions:

• No single agreement measure is universally superior; interpretation requires considering multiple factors.
• Guidelines are provided for selecting and interpreting agreement measures for clinical trial endpoint validation.
• The study offers practical insights for assessing endpoint reliability in clinical trial design.